Company news

Microbix Biosystems Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

eResearch Issues Initiating Report on Microbix Biosystems Inc.

July 8, 2011

Microbix Announces $210,000 Private Placement

July 6, 2011

Hunan Influenza Vaccine Joint Venture on Hold Pending Resolution of Contract Renegotiation

June 27, 2011

eResearch Issues Perspective on Microbix Biosystems Inc.

June 24, 2011

Microbix Biosystems Receives Notice of Allowed Patent Claims in Patent Application for LumiSort(tm) Livestock Semen Sexing Technology

June 23, 2011

eResearch.ca Issues Research Report on Microbix Biosystems Inc.

May 19, 2011

Microbix Reports Second Quarter Results and Provides Update on Hunan Joint Venture

May 16, 2011

Microbix Extends Expiry Date of Share Purchase Warrants

May 5, 2011

Microbix Announces Proof-of-Concept Demonstration for LumiSort(tm)? its Livestock Semen Sexing Technology

May 4, 2011

Microbix wins European Patent protection for VIRUSMAX(tm), its vaccine production technology that dramatically increases yields

April 26, 2011

Microbix Announces Closing of Second Tranche of Private Placement of $577,500

April 19, 2011

Microbix Announces $140,000 Private Placement

April 1, 2011

Microbix Further Strengthens Patent Position for LumiSort? -- its Livestock Semen Sexing Technology

February 16, 2011

Microbix Reports First Quarter Results

February 14, 2011

Microbix' CEO Statement on Universal Vaccine

February 8, 2011

Microbix Appoints CEO and Chairman of its New Vaccine Joint Venture in China

January 18, 2011

Microbix' CEO Sells Shares to Invest in China Vaccine Joint Venture

January 6, 2011

Microbix Completes $600,250 Private Placement

December 6, 2010

Microbix Creates Influenza Vaccine Subsidiary and Announces Over-Subscribed Financing to Support the Start-up of its China JointVenture

December 2, 2010

Microbix Has Best-Ever Quarterly Sales

October 20, 2010

Microbix Reports 11% Growth In Product Volume For Nine Months

August 12, 2010

Microbix Reports 11% Growth in Product Volume for Nine Months

August 12, 2010

Microbix Reports a Record Increase in Worldwide Sales for 2nd Quarter 2010

May 13, 2010

TSX takes off like a rocket

February 16, 2010

Microbix Cash-Flow Position Improves Markedly in 1st Quarter; Expects Strong 2nd Quarter & Second Half 2010

February 16, 2010

Microbix Completes $1,300,000 Private Placement

February 13, 2010

Microbix And Therapure Biopharma Form Partnership To Expand Water-Based Supplies To The Pharma Industry

January 12, 2010

Microbix' Pipeline Set To Reach Milestones In 2010

December 16, 2009

Microbix Signs Marketing Agreement For Kinlytic(R)(Urokinase) In Growing Middle East Region

November 17, 2009

Microbix Receives Approval To Market Thrombolytic Agent Kinlytic(TM) (urokinase) In Canada

November 10, 2009

Microbix Biosystems Re-files Annual Results With OSC

November 6, 2009

Microbix Biosystems Provides a Corporate Update

October 29, 2009

Microbix And Hunan Biopharmaceutical To Build Asia's Largest Influenza Vaccine Facility

October 27, 2009

Microbix Completes $752,275.65 Private Placement

September 10, 2009

Microbix to Present at Rodman & Renshaw Investor Healthcare Conference. Management to Highlight Pipeline Opportunities.

September 3, 2009

Microbix Announces A $750,000 Private Placement

August 28, 2009

Microbix Sales Grow 22% For Nine Months

August 6, 2009

Microbix Files First Patent Applications On Novel Technology Platform For Large Semen Sexing Market

July 9, 2009

Microbix Sales Grow Over 30% In The Second Quarter; Up 43% In The First Half '09

May 14, 2009

Microbix Announces A New Technology Platform For The SST Project

April 7, 2009

Microbix First Quarter Sales Grow Over 50% With Continued Progress On The Pipeline

February 13, 2009

Microbix Uses Core Business Cashflow To Fund Late-Stage Pipeline To Build Shareholder Value In 2009

December 10, 2008

Microbix Enters The Urokinase Market

September 24, 2008

Microbix Continues Progress in Implementing Strategic Plan in Q3

August 13, 2008

Microbix Enters into Joint Venture in China to Build and Operate One of the Largest Influenza Vaccine Manufacturing Facilities in the World

June 23, 2008

Microbix and ImaRx Agree to Terminate Letter of Intent

June 11, 2008

Microbix VIRUSMAX(TM) Technology Continues to Attract Interest from Vaccine Manufacturers

June 5, 2008

Reporters/Editors: ^China grants patent protection to Microbix for its influenza vaccine yield enhancement technology

May 27, 2008

Microbix Makes Significant Progress in Implementing Strategic Plan in Q2

May 14, 2008

Microbix to spin off Urokinase into newly formed Klarogen Biotherapeutics; Klarogen to acquire all remaining Urokinase inventory, sales and marketing infrastructure and NDA from ImaRx upon completion of financing

May 7, 2008

← Newer news releases · Older news releases →

Calls

The 5 newest of 12 calls. Every call is listed under its year.

Decks

The 5 newest of 7 decks. Every deck is listed under its year.